
OBL-1 SM
10MG · per vial
Purity
≥99% (HPLC)
Form
White to off-white lyophilised powder
About This Compound
OBL-1 SM is a long-acting GLP-1 receptor agonist, an acylated analogue of the native incretin sequence modified at position 8 to resist DPP-4 cleavage and bound to a C18 diacid chain for albumin affinity. It is used in receptor-pharmacology and incretin-signalling studies. Supplied lyophilised, sealed under inert gas. Research use only. Not for human or veterinary use.
Compound class
Certificate of Analysis
OBL-1 SM 10MG
For laboratory research use only. Not a drug, food additive, cosmetic, or dietary supplement. Not for human or veterinary consumption.
Specifications
Physical and analytical data for this compound, recorded against the tested batch. Identity and purity results are published in the Certificate of Analysis.
- Purity
- ≥99% (HPLC)
- Endotoxin
- <1 EU/mg (LAL)
- Appearance
- White to off-white lyophilised powder
- Solubility
- Soluble in bacteriostatic or sterile water
- Storage
- Lyophilised: −20°C, protected from light. Reconstituted: 2–8°C, use within 30 days.
